Anti-GD2-800CW
SP_PS21DIN
Phase 2 small_molecule active
Quick answer
Anti-GD2-800CW for Neuroblastoma is a Phase 2 program (small_molecule) at AXIM BIOTECHNOLOGIES, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AXIM BIOTECHNOLOGIES, INC.
- Indication
- Neuroblastoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active